Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s):  IPCIF

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several... see more

TSXV:IPCI.H - Post Discussion

Intellipharmaceutics International Inc > here we go news on the way bottom up insome hold long too
View:
Post by ROUGETRADER719 on Oct 21, 2019 10:38am

here we go news on the way bottom up insome hold long too

GLTA market caps a joke ...it will get picked up soon enough
Comment by biggerr on Oct 21, 2019 12:49pm
I think they'll have to find some replacement for Mallinckrodt to sell their drugs Also I like how every time they make a PR they say that there is no guarantee that they'll sell any of their drugs or that they get an FDA approval or even if they'll exist tomorrow or an asteroid won't hit the Earth and so on, ha 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities